清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

The Tumorigenic Effect of the High Expression of Ladinin-1 in Lung Adenocarcinoma and Its Potential as a Therapeutic Target

癌症研究 生物
作者
Lei Hu,Yu Liu,Changfang Fu,Jiarong Zhao,Qianwen Cui,Qiuyan Sun,Hongqiang Wang,Li Lu,Haiming Dai,Xiaohui Xu,Wulin Yang
出处
期刊:Molecules [Multidisciplinary Digital Publishing Institute]
卷期号:28 (3): 1103-1103 被引量:10
标识
DOI:10.3390/molecules28031103
摘要

The oncogenic role of Ladinin-1 (LAD1), an anchoring filament protein, is largely unknown. In this study, we conducted a series of studies on the oncogenic role of LAD1 in lung adenocarcinoma (LUAD). Firstly, we analyzed the aberrant expression of LAD1 in LUAD and its correlation with patient survival, tumor immune infiltration, and the activation of cancer signaling pathways. Furthermore, the relationship between LAD1 expression and K-Ras and EGF signaling activation, tumor cell proliferation, migration, and colony formation was studied by gene knockout/knockout methods. We found that LAD1 was frequently overexpressed in LUAD, and high LAD1 expression predicts a poor prognosis. LAD1 exhibits promoter hypomethylation in LUAD, which may contribute to its mRNA upregulation. Single-sample gene set enrichment analysis (ssGSEA) showed that acquired immunity was negatively correlated with LAD1 expression, which was verified by the downregulated GO terms of "Immunoglobulin receptor binding" and "Immunoglobulin complex circulating" in the LAD1 high-expression group through Gene Set Variation Analysis (GSVA). Notably, the Ras-dependent signature was the most activated signaling in the LAD1 high-expression group, and the phosphorylation of downstream effectors, such as ERK and c-jun, was strongly inhibited by LAD1 deficiency. Moreover, we demonstrated that LAD1 depletion significantly inhibited the proliferation, migration, and cell-cycle progression of LUAD cells and promoted sensitivity to Gefitinib, K-Ras inhibitor, and paclitaxel treatments. We also confirmed that LAD1 deficiency remarkably retarded tumor growth in the xenograft model. Conclusively, LAD1 is a critical prognostic biomarker for LUAD and has potential as an intervention target.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Lan完成签到 ,获得积分10
5秒前
13秒前
冷傲的夜白完成签到,获得积分10
14秒前
JUN完成签到,获得积分10
21秒前
25秒前
瞿人雄完成签到,获得积分10
25秒前
007发布了新的文献求助30
29秒前
葵辰完成签到 ,获得积分10
30秒前
31秒前
31秒前
31秒前
35秒前
maprang完成签到,获得积分10
55秒前
李爱国的应助被levosimendan采纳,获得10
56秒前
木齐Jay完成签到,获得积分10
1分钟前
无花果的应助被粉色紫米粥采纳,获得10
1分钟前
007完成签到,获得积分10
1分钟前
1分钟前
领导范儿的应助被xun采纳,获得10
2分钟前
悲凉的丝完成签到,获得积分10
2分钟前
2分钟前
汉堡包的应助被科研通管家采纳,获得10
2分钟前
2分钟前
2分钟前
2分钟前
欠欠发布了新的文献求助10
2分钟前
明月朗晴完成签到 ,获得积分10
2分钟前
drkyy完成签到,获得积分10
2分钟前
天天快乐的应助被whc采纳,获得10
2分钟前
2分钟前
2分钟前
levosimendan发布了新的文献求助10
2分钟前
风趣的夏波完成签到,获得积分10
2分钟前
whc发布了新的文献求助10
2分钟前
oleskarabach完成签到,获得积分20
3分钟前
3分钟前
xun发布了新的文献求助10
3分钟前
3分钟前
酷波er的应助被xun采纳,获得10
3分钟前
levosimendan发布了新的文献求助10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190159
求助须知:如何正确求助?哪些是违规求助? 9577264
关于积分的说明 21852297
捐赠科研通 7788567
什么是DOI,文献DOI怎么找? 3436279
关于科研通互助平台的介绍 2560058
邀请新用户注册赠送积分活动 2482880